Table 2.
Model-Generated CKRT Demand, Capacity, and Shortage at Peak Resource Use During the Initial Wave of the COVID-19 Pandemic
| State | CKRT Demand at Peak Resource Use (95% UI)a | CKRT Capacity | Projected CKRT Shortage | CKRT Shortage at Peak Resource Use (95% UI)a |
|---|---|---|---|---|
| Alabama | 59 (57-62) | 167 | No | — |
| Alaska | 3 (3-4) | 10 | No | — |
| Arizonab | 78 (58-233) | 122 | Possible | 0 (0-110) |
| Arkansas | 27 (20-63) | 65 | No | — |
| California | 274 (258-292) | 627 | No | — |
| Coloradob | 59 (53-242) | 101 | Possible | 0 (0-141) |
| Connecticutc | 143 (127-162) | 59 | Yes | 85 (68-104) |
| Delaware | 18 (17-20) | 25 | No | — |
| District of Columbia | 24 (22-27) | 32 | No | — |
| Florida | 209 (199-239) | 552 | No | — |
| Georgia | 126 (115-203) | 258 | No | — |
| Hawaii | 6 (6-7) | 19 | No | — |
| Idaho | 9 (8-10) | 23 | No | — |
| Illinois | 217 (199-238) | 266 | No | — |
| Indiana | 104 (98-111) | 183 | No | — |
| Iowa | 29 (26-35) | 43 | No | — |
| Kansas | 24 (23-26) | 64 | No | — |
| Kentucky | 46 (44-49) | 124 | No | — |
| Louisianab | 119 (109-129) | 117 | Possible | 2 (0-12) |
| Maine | 10 (8-22) | 24 | No | — |
| Marylandc | 130 (112-151) | 106 | Yes | 24 (5-45) |
| Massachusettsc | 159 (146-172) | 130 | Yes | 29 (16-42) |
| Michiganc | 255 (235-277) | 234 | Yes | 21 (1-43) |
| Minnesota | 55 (52-59) | 109 | No | — |
| Mississippi | 41 (39-46) | 71 | No | — |
| Missouri | 63 (61-66) | 161 | No | — |
| Montana | 5 (5-5) | 18 | No | — |
| Nebraskab | 20 (16-55) | 46 | Possible | 0 (0-9) |
| Nevada | 42 (41-44) | 115 | No | — |
| New Hampshire | 14 (12-17) | 19 | No | — |
| New Jerseyc | 410 (381-442) | 138 | Yes | 272 (243-304) |
| New Mexicob | 22 (20-44) | 36 | Possible | 0 (0-8) |
| New Yorkc | 1,019 (939-1,104) | 363 | Yes | 656 (576-741) |
| North Carolina | 105 (97-144) | 298 | No | — |
| North Dakota | 9 (8-18) | 24 | No | — |
| Ohio | 140 (132-149) | 307 | No | — |
| Oklahoma | 36 (34-37) | 97 | No | — |
| Oregon | 22 (21-23) | 66 | No | — |
| Pennsylvania | 239 (221-259) | 293 | No | — |
| Rhode Islandb | 25 (23-28) | 27 | Possible | 0 (0-1) |
| South Carolinab | 58 (46-136) | 131 | Possible | 0 (0-6) |
| South Dakota | 5 (5-6) | 10 | No | — |
| Tennessee | 82 (67-159) | 225 | No | — |
| Texas | 207 (199-217) | 604 | No | — |
| Utah | 19 (15-36) | 47 | No | — |
| Vermont | 3 (2-3) | 6 | No | — |
| Virginia | 89 (84-94) | 173 | No | — |
| Washington | 34 (60-66) | 128 | No | — |
| West Virginia | 17 (17-18) | 55 | No | — |
| Wisconsin | 44 (42-49) | 110 | No | — |
| Wyomingb | 3 (2-6) | 5 | Possible | 0 (0-1) |
Note: This analysis uses the base-case values for the input parameters listed in Table 1. Minor discrepancies in numerical values in the table are due to rounding.
Abbreviations: CKRT, continuous kidney replacement therapy; COVID-19, coronavirus disease 2019; UI, uncertainty interval.
We derived these estimates from the Institute for Health Metrics and Evaluation model and present them as means with 95% UI.16
Represents states that could possibly encounter a shortage (where CKRT capacity is within the 95% UI of CKRT demand).
Represents states that are projected to encounter a shortage (where CKRT capacity is below the 95% UI of CKRT demand).